GSK3816302A
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK3816302A, covering 2021-05-07 to 2021-05-07. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Reactogenicity, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Supra-seasonal Universal Influenza Vaccines - Inactivated (SUIVs) (GSK3816302A) in Healthy Adults Aged 18 to 39 Years [Phase 1]